相关实验视频
Updated: May 25, 2025

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.0K
由肠道微生物群调节的老年性骨关节炎:从机制到治疗方法
Fan Yu1, Chenyu Zhu1, Wei Wu2
1School of Exercise and Health, Shanghai University of Sports, Shanghai 200438, China.
International journal of molecular sciences
|February 26, 2025
概括
衰老和骨关节炎 (OA) 与肠道微生物群的变化有关. 调节肠道细菌可能为与年龄相关的关节退化提供新的治疗方法.
科学领域:
- 老年病理学和风湿病理学
- 微生物组研究 微生物组研究
- 退行性关节疾病 退行性关节疾病
背景情况:
- 骨关节炎 (OA) 是一种进展性关节疾病,导致软骨退化,显著影响生活质量和整体残疾.
- 晚年是OA的主要风险因素,软骨退化的增加和与衰老相关的磨损.
- 新兴研究表明,肠道微生物群在衰老和OA的发病过程中起着重要作用.
研究的目的:
- 为了研究肠道微生物群组成和老年性骨关节炎之间的复杂关系.
- 探索肠道微生物群影响与年龄相关的OA的潜在机制.
- 审查目前和新兴的治疗策略,以肠道菌群为目标.
主要方法:
- 对检查肠道微生物群和骨关节炎的研究进行了全面的文献综述.
- 分析肠道失调,衰老和关节退化之间的潜在机械联系.
- 综合了包括益生菌,益生菌,饮食,运动,TCM和便微生物群移植 (FMT) 在内的治疗干预措施的数据.
主要成果:
- 肠道微生物群的变化越来越被认为是导致OA发展和进展的因素,特别是在老年人群中.
- 通过各种干预措施对肠道微生物群的调节显示出管理OA症状和病理的潜力.
- 将这些发现转化为可靠的临床应用仍然存在重大挑战.
结论:
- 肠道微生物群是对抗与年龄相关的骨关节炎的有希望的治疗点.
- 需要进一步的研究来阐明具体的机制,并优化基于微生物群的干预措施.
- 这一审查为未来的微生物向性OA疗法研究方向奠定了基础.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Irritable Bowel Syndrome I: Introduction
218
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
218
Inflammatory Bowel Disease IV: Pharmacological Management
89
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
89
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
294
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
294
What is Monogastric Digestion?
70.4K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.4K
Peptic Ulcer Disease IV: Management
58
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
58

